In patients with presumed PR, the presence of autoantibodies can predict the presence of an underlying neoplasm (i.e., anti-recoverin autoantibodies), but their diagnostic value is not fully understood [42,43,44]. The gene discussed is RCVRN; the disease is neoplasm.